Notice to Convene the Annual General Meeting of Genmab A/S
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Truist Securities Reiterates Buy Rating on Genmab A/S (GMAB)
February 13, 2025 7:17 AM ESTTruist Securities analyst Asthika Goonewardene reiterated a Buy rating and $50.00 price target on Genmab A/S (NASDAQ: GMAB).
The analyst comments "We believe investors are anxious to own GMAB ahead of J&J's (JNJ, Not Rated) decision to opt-in on GEN3014, and... More
